The Chinese Food and Drug Administration have just opened a huge new market for a revolutionary, essentially risk-free prenatal test for the three most common genetic diseases. The NIFTY test, designed by the Beijing Genomics Institute, is a simple, highly accurate, and non-invasive genetic testing kit that is now available to millions of Chinese women.…Details
The art of creating cheese is a tale as old as time, dating back thousands of years. This tradition is changing because of a team of citizen scientists, bio-hackers, biotech-engineers, and computer scientists from the Bay area in San Francisco. According to the video and USA TODAY, 60% of adults are considered lactose intolerant. These…Details
A major stumbling block to the amateur or professional scientist is the lack of complex, expensive equipment with which to conduct experiments. Emerald Therapeutics aims to solve this issue with its new division, Emerald Cloud Lab. The company aims to democratize scientific experimentation by allowing scientists to design, conduct, and analyse experiments and experimental data…Details
Imagine if somebody patented the book. Or a nut-and-bolt. This is how Tony Fong of Genome Web Daily news would compare the patenting the CRISPR-Cas9 gene editing technology, recently awarded to the Broad Institute. In the same way that any modern mechanics would be impossible without the use of basic tools, the future of cost-effective…Details
Without a focused direction and a specific organization in charge and shouldering responsibility for development, the genetic product can just as quickly innovate explosively as become neglected and die. Despite the ruling by United States Supreme Court that human genes cannot be patented, the war between open- and closed-source synthetic biology continues to rage. Both…Details
Imagine a world without surgery. Thanks to scientists: Ido Bachelet, Shawn Douglas and the lab of George Church at Harvard Medical School, this world is in the making. Ido Bachelet, Shawn Douglas and other accredited scientists have been using synthetic biology to create surgical Nano-robotics, which mimic the functions of a computer processor. Instead of…Details
Simplifying Synthetic Biology: The Compilation Design Rules Engine Genome Compiler’s new Compilation Design Rules Engine ensures users that their synthetic biology projects follow nature’s engineering constraints as well specific rules from the industry’s most prominent synthesizers. Also look forward for future releases to establish your own design constraints as well. Debugging complex synthetic biology work has…Details
CRISPR engulfed in Intellectual Property debacle. What will this fight mean for the future of Synbio?
The United Kingdom’s Independent has released details of a debate amongst the originators of the CRISPR method of genome engineering continuing to rage this May. This battle for the monetary spoils of such a tremendous scientific advancement has gripped former colleagues at premier institutions on two continents. As the French team of Dr. Emmanuelle Charpentier…Details
The progress of Glowing Plant, one of Genome Compiler’s flagship synbio partners and personal undertaking of Genome Compiler CEO Omri Amriav-Dory (as strategic adviser), has once again piqued the interest of the Wall Street Journal. In a series of recent blog articles and online videos, Wall Street Journal’s Deborah Kan has interviewed Glowing Plant’s CEO…Details
We are excited to announce our new online demo of Genome Compiler, available just a few clicks away directly within your web browser! Now you can experience the basics of Genome Compiler’s powerful abilities without as much as a download. Get to know Genome Compiler’s innovative user interface and intuitive tools for efficient and flexible…Details
This week, the synthetic biology community is excited to add two new materials to its genetic toolbox. Researchers at The Scripps Research Institute of La Jolla, California have announced the successful synthesis of two entirely synthetic nucleobases with the ability of incorporating the new proteins into the DNA of E. Coli bacteria. These breakthrough findings…Details
Rob Carlson is one of the world's leading experts on biotechnology, particularly synthetic biology, and spends a lot of his time analyzing the industry in order to help biotech companies do well in the evolving market. While many in the field believe that expensive DNA synthesis is the only thing blocking an explosion of the…Details
Primate models could be especially helpful to researchers trying to make sense of the growing number of mutations that genetic studies have linked to brain disorders. The significance of a specific genetic variant is often unclear; it could be a cause of a disorder, or it could just be indirectly associated with the disease. CRISPR…Details
With the most recent triumph of developing the world’s first completely synthetic eukaryotic chromosome under the leadership of Dr. Jef Boeke’s Johns Hopkins lab it is clear that ambitions within the field of Synthetic Biology are growing larger every day. With these incredible undertakings come larger sequences, and with these larger sequences come larger teams…Details
Genome Compiler is happy to confirm that the litigation between DNA2.0 and GCC has been settled. As part of the settlement, DNA2.0 has granted GCC a worldwide license, covering GCC, it's customers and it's users.
Read more analysis on the subject from a third party perspective .
Read Official Settlement here.
Recent findings out of Purdue University have the potential to electrify the field of agricultural genetic engineering. In early March a team led by Stanton Gelvin Ph.D has perfected techniques to modify genetic sequences of plant species previously known to be nearly unalterable by the field’s prevailing method. Dr. Gelvin’s team uses an intuitive method…Details
Instead of just copying nature, the team did extensive tinkering with their chromosome, deleting unwanted genes here and there. It then successfully incorporated the designer chromosome into living yeast cells, endowing them with new capabilities not found in naturally occurring yeast. The most familiar yeast is commonly referred to as brewers’ yeast, saccharomyces cerevisiae, which is a…Details
In the ever-growing field of synthetic biology, continuously increasing numbers of funding providers and resources for entrepreneurs are boosting innovation. Standing out among all of this support is SynBio Axlr8r, a 90-day accelerator for synthetic biology startups in the idea stage. Funded by SOSventures, SynBio Axlr8r is working to bring synthetic biology innovators to Cork,…Details
"However, gathering the silk from farm-raised spiders, which are territorial and cannibalistic, is not an option. Firms attempting to make spider silk synthetically have copied relevant genes from spiders and inserted them into organisms, such as Escherichia coli, that can express the protein. The protein, though, is complex, and producing silk that is as strong as nature’s…Details
Venture Beat published an article discussing the acceleration of data, technology, and human capability. The article examined the future of bio-tech and GC was recognized as a leader in the field. The re-emergence of BioTech, or BioTech 2.0, is a great example of innovation in automating procedures on top of newly procured datasets. Companies like Transcriptic are…Details
Most known cancers in humans have 1000 to 5000 mutations to its DNA, but scientists located at the University of Cambridge and the Wellcome Trust Sanger Institute, headed by Elizabeth Murchison, have just published their discovery of an 11,000-year-old cancer with 1.9 million mutations in its genome, making it the oldest cancer to be discovered. This…Details